View Older Stories View More Recent Stories

May 2, 2023 04:30PM Be Biopharma Announces First Scientific Disclosures and New Preclinical Data Supporting the Advancement of B Cell Medicines at the American Society of Gene & Cell Therapy 26th Annual Meeting
Apr 18, 2023 04:30PM Form SC 13D/A Satsuma Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 18, 2023 12:05PM Cortica Closes $75 Million in New Funding Round and Acquires Springtide Child Development
Apr 18, 2023 08:30AM Ocelot Bio Appoints Lise Kjems, M.D., Ph.D., as Chief Medical Officer
Apr 16, 2023 01:30PM Adela presents data demonstrating strong detection of 12 cancer types at the American Association for Cancer Research Annual Meeting 2023
Apr 13, 2023 03:30AM Adcendo ApS to Present Data on the Expression of the Novel ADC target uPARAP in Soft Tissue and Bone Sarcoma at the 2023 American Association for Cancer Research (AACR) Annual Meeting
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:15AM Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis
Apr 13, 2023 01:00AM Alentis Therapeutics Closes $105 Million Series C Funding to Advance Transformational Medicines for Claudin-1
Apr 13, 2023 01:00AM Novo Holdings invests in US$105 million Series C Funding of Alentis Therapeutics
Apr 10, 2023 05:05PM Form SC 13G NanoString Technologies Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 10, 2023 05:02PM Form SC 13D/A Eliem Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 10, 2023 05:01PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.
Apr 10, 2023 08:00AM MBX Biosciences to Participate in the Needham 22nd Annual Healthcare Conference
Apr 4, 2023 03:30AM Over DKK 3 billion (USD 413 million) raised by BioInnovation Institute portfolio companies to date
Apr 4, 2023 03:00AM Adcendo ApS Announces Extension of Series A Financing to 82M EUR to Ensure Broad Development of its First-in-class ADC Pipeline
Mar 31, 2023 10:00AM Scribe Therapeutics to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days
Mar 30, 2023 05:09PM Form SC 13G/A GH Research PLC Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 30, 2023 05:07PM Form SC 13D/A Acrivon Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 30, 2023 05:03PM Form SC 13D/A 89bio, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 29, 2023 05:14PM Form SC 13D/A DICE Therapeutics, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 27, 2023 05:00PM Form SC 13G CureVac N.V. Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 20, 2023 04:30PM Form SC 13G Orchard Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Mar 16, 2023 08:00AM Jnana Therapeutics to Present Preclinical Data on its PKU Program at the 2023 Society for Inherited Metabolic Disorders Annual Meeting
Mar 15, 2023 09:00AM Adela to present data demonstrating detection of multiple cancer types at the American Association for Cancer Research Annual Meeting 2023
Mar 12, 2023 04:07PM RA Capital Urges Swift Federal Response to SVB Crisis
Mar 7, 2023 08:00AM LENZ Therapeutics Announces $83.5 Million Series B Financing to Advance its Presbyopia Treatments LNZ100 and LNZ101 and Provides Update on Ongoing Phase 3 Studies
Mar 7, 2023 08:00AM MBX Biosciences to Participate in the Oppenheimer 33rd Annual Healthcare Conference
Mar 6, 2023 06:30AM Bicara Therapeutics Announces Oversubscribed $108 Million Series B Financing to Advance Clinical-Stage Pipeline of Dual-Action Biologics to Treat Cancer
Mar 6, 2023 06:03AM Orchard Therapeutics Plc (ORTX) Enters Up to $188M Strategic Financing
Mar 6, 2023 06:00AM Orchard Therapeutics Announces Strategic Financing Totalling up to $188 Million
Mar 6, 2023 06:00AM Orchard Therapeutics Announces Strategic Financing Totalling up to $188 Million
Mar 2, 2023 09:00AM TeraPore Technologies Raises $10M to Bring Precision Nanofiltration Solutions to New Markets
Mar 1, 2023 08:00AM Jnana Therapeutics to Participate in Upcoming Investor Conferences
Feb 28, 2023 07:00AM Third Annual Science2Startup (S2S)™ Symposium on May 3, 2023 Will Foster Collaboration Between Researchers, Entrepreneurs and Top Investors
Feb 27, 2023 04:59PM Form SC 13G/A Enliven Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
View More Recent Stories View Older Stories